AKT1 and cholangiocarcinoma: PI3K activation in response to integrin signalling is well documented in cancer, and there are some reports of Akt activation leading to tumour cell invasion in response to integrin-mediated periostin signalling in epithelial tumours, eg integrin α5β1 in cholangiocarcinoma [47].